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Background: Blomia tropicalis is a dust mite and an important source of allergens in tropical regions. Up to now,
the assays to diagnose atopy to this mite use whole body extract as antigens. However, anti-B. tropicalis IgE
antibodies cross-react with Ascaris lumbricoides antigens, hindering the diagnosis of allergy to this mite. In this
study, B. tropicalis recombinant allergens were evaluated with the purpose of developing an immunodiagnostic
assay for allergy to this mite with greater specificity than those commercially available.
Methods: Two B. tropicalis allergens (Blo t 5 and Blo t 21) were cloned into a plasmidial expression vector,
expressed in Escherichia coli and purified by affinity chromatography. Sixty-three sera containing anti-B. tropicalis
extract (BtE) IgE antibodies were used to investigate IgE reactivity to the recombinant Blot 5 and 21 allergens.
Inhibition assays with 20 sera pre-adsorbed with A. lumbricoides extract were performed using rBlo t 5, rBlo t 21,
and BtE as antigens. All the assays were carried using indirect ELISA.
Results: Eighty-two point nine percent and 80.0% of the sera with anti-BtE antibodies from 35 children reacted
with rBlo t 5 and rBlo t 21, respectively, whereas 92.8% and 89.3% of the 28 sera with anti-BtE antibodies from adult
asthma patients reacted with the same allergens, and 96.4% of these sera reacted with a mixture of rBlo t 5 and
rBlo t 21. In an inhibition ELISA, the absorption of sera by A. lumbricoides extract affected less the reaction with rBlo
t 5 and rBlo t 21 than with BtE.
Conclusions: The rBlo t 5 and rBlo t 21 allergens contain important epitopes recognized by IgE antibodies of
individuals allergic to B. tropicalis antigens. Moreover, the assays using the recombinant allergens had lower IgE
cross-reactivity with A. lumbricoides antigens, a fact which would confers higher specificity to serodiagnostic assays
than the crude mite extract. However, additional recombinant allergens should be evaluated in order to reach the
same sensitivity of the commercially available assays based on mite extract.
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Allergic respiratory diseases, like asthma and rhinitis, are
worldwide spread and their prevalences have increased
over the past decades, reaching epidemic proportions [1].
Mite-allergen sensitization is a well-documented risk fac-
tor for asthma and allergic diseases in atopic individuals.
In tropical regions of the world, Blomia tropicalis and
Dermatophagoides pteronyssinus are predominant in
house dust and are commonly found together [2,3].
B. tropicalis mite is the major source of indoor allergens
in the northeastern cities of Brazil [4,5]. Clinical history,
skin prick test (SPT) results and specific IgE detection are
the tripod for the diagnosis of allergic diseases. The major-
ity of the methods for detecting anti-allergen IgE anti-
bodies is based on the use of natural allergenic extracts, a
fact that may compromise the interpretation of their re-
sults. Natural allergen extracts are highly complex molecu-
lar mixtures, containing many proteins, of which only
some have allergenic properties, and with their relative
contents varying greatly from one extract to another [6,7].
Caraballo and collaborators [2] described at least 25 IgE-
binding protein bands in B. tropicalis crude extract.
Around 12 recombinant allergens have been molecularly
and immunologically characterized and deposited into the
allergen database, according to International Union of
Immunological Societies (IUIS) Allergen Nomenclature
(www.allergen.org). Among these allergens, it includes Blo
t 1 (cysteine protease, 26 kDa), Blo t 3 (trypsin protease,
25 kDa), Blo t 5 (unknown molecular function, 14 kDa),
Blo t 11 (paramyosin, 110 kDa), Blo t 12 (unknown mo-
lecular function, 14 kDa), and Blo t 21 (unknown molecu-
lar function, 13.2 kDa), which are present in 50% or more
of the sera from B. tropicalis-sensitized individuals [3,4].
Blo t 5 and Blo t 21 represent the major allergens in
B. tropicalis mite. These allergens share some structural
similarities determined by NMR consisting of three anti-
parallel α-helices, assembled in a helical bundle. Despite
the fact that some putative IgE epitope residues are con-
served in both Blo t 5 and Blo t 21 three-dimensional
structures, these allergens present a low to moderate
cross-reactivity [5,8].
Nevertheless, the IgE-binding properties to these aller-
gens may vary depending on several factors, such as gen-
etic background of the study population, frequency of
mite sensitization, and intrinsic molecular characteristics
of the allergens, such as isoform expression profile [3].
Furthermore, in tropical regions of the world, where the
high prevalence of helminth infections is a public health
problem, the serodiagnosis of allergic diseases may be
compromised by cross-reactive antibody to epitopes
shared by mite and helminths [9,10].
In this study we produced B. tropicalis recombinant
allergens (rBlo t 5 and rBlo t 21) in a prokaryotic system,
based on sequences obtained in the GenBank database.A total of 63 sera with IgE antibodies reacting with B.
tropicalis extract (BtE), from asthmatic patients and from
atopic children from Salvador, a large urban center in
northeastern Brazil, were used to investigate IgE reactivities
to the recombinant Blo t 5 and Blo t 21 allergens by indir-
ect ELISA. The cross-reactivities of IgE antibodies between
B. tropicalis (crude extract and recombinant allergens) and
A. lumbricoides (crude extract) were also evaluated.
Methods
B. tropicalis and A. lumbricoides extracts
An ether-treated extract of B. tropicalis mite, obtained
from house dust samples in Salvador, was prepared
according to Baqueiro and collaborators [11]. Briefly, B.
tropicalis was collected from bed dust in Salvador, Brazil,
cultured with a fish food medium, at 25°C and 75% hu-
midity and cloned. The mites were purified from the
medium by flotation on a 5 M sodium chloride solution,
followed by several washings by filtration in a 100 μm-
pore polystyrene sieve with endotoxin-free distilled
water. The washings were carried out until no food resi-
dues were seen under microscopy. The mites were lysed
in 0.15 M phosphate-buffered saline, pH 7.4 (PBS), in an
electric blender (Waring Commercial, Torrington, CN,
USA). Lipids from the lysate were extracted by five or
six ether extractions and discarded. The protein content
of the B. tropicalis aqueous extract was determined by
the Folin reagent method [12]. The extract was stan-
dardized using a commercially available capture ELISA
for detection of Blo t 5 allergen. (INDOOR Biotechnolo-
gies, Charlottesville, VI, USA), with the Blo t 5 content
in the extract established at 200 ng per mg of total pro-
tein, and subsequently aliquoted and cryopreserved until
use. The A. lumbricoides aqueous extract was prepared
from adult worms obtained from infected albendazol and
bisacodyl-treated children in Salvador, Brazil, according
to Ponte and collaborators [9].
B. tropicalis recombinant allergens
Sequences encoding B. tropicalis allergens (Blo t 5 and Blo
t 21) were obtained from their deposits in the GenBank
database. The selection criterion was based on published
analysis of the frequency of allergic patients' sera with IgE
antibody reactivity to the recombinant allergens (50% or
more reactivity with the tested sera) [3,4]. Pairs of primers
(50-30) were designed based on the published full length
nucleotide sequence of Blo t 5 and Blo t 21 (GenBank:
U59102 and GenBank: AY800348, respectively), which
allowed their amplification by polymerase chain reaction
(PCR) flanked by restriction enzyme sites for BamHI/XhoI
(Blo t 5, forward – CCCGGATCCATGAAGTTCGCCA
TCGTTC; reverse - GGGCTCGAGTTATTGGGTTTG
AATATC) or BamHI/HindIII (Blo t 21, forward - CC
CGGATCCATGAAATTTATCATCGCATTG; reverse –
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tropicalis cDNA library had already been constructed in
our laboratory, an aliquot of it was used as template for
the PCR. The Blo t 5 and Blo t 21 amplicons were ligated
to the pRSETA expression vector and used for trans-
forming DH-10 B-strain Escherichia coli. The bacteria
were cultivated and plasmid DNAs were obtained and se-
quenced. All sequences were aligned and homology ana-
lysis was performed using the BLAST network service
provided by NCBI. Constructs containing Blo t 5 and Blo t
21 were then used to transform BL21(DE3) E. coli BL21
(DE3)pLysS, generating His (histidine)-tagged proteins
(His-rBlo t 5 and His-rBlo t 21) after induction with 0.1
mM isopropyl β-D-thiogalatoside (IPTG). The recombin-
ant proteins were subsequently purified by affinity chro-
matography using the Ni-NTA agarose resin (QIAGEN
Biotecnologia Brasil Ltda; São Paulo, SP, Brazil), according
to the manufacturer's protocol.
Polyacrylamide gel electrophoresis and IgE immunoblot
assays
His-rBlo t 5 and His-rBlo t 21 recombinant proteins were
subjected to polyacrylamide gel electrophoresis in the
presence of sodium dodecyl sulphate (SDS-PAGE; Merck
& Co., Inc., White House Station, NJ, USA), according to
Laemmli [13], using a Mini-PROTEAN III Electrophoresis
Cell (Bio-Rad Laboratories, Hercules, CA, USA), followed
by electroblotting onto nitrocellulose membrane (Sigma,
St Louis, MO, USA). Immunoblotting was then carried
out to determine the reactivities of anti-allergen serum
IgE antibodies to these fusion proteins. Briefly, the blots
were blocked with 0.15 M phosphate-buffered saline, pH
7.2 (PBS) containing 0.05% Tween (PBS/T) and 10% (w/v)
dry non-fat milk for at least two hours at room
temperature, followed by overnight incubation with con-
tinuous shaking at 4°C with human sera diluted 1:10 in
PBS/T containing 5% dry non-fat milk. The blots were in-
cubated with mouse anti-human IgE:HRP monoclonal
antibody (ABCAM,Cambridge, UK) at room temperature
for one hour. The reaction was developed using H2O2 and
diaminobenzidine (DAB) as substrate and chromogen, re-
spectively (Sigma, St. Louis, MO, USA). Between all steps,
the blots were washed three times with PBS/T followed by
two washes with PBS alone.
Serum samples
Thirty five of the 63 studied sera were obtained from
atopic children living in Salvador, Bahia, Brazil. Atopy in
these children was characterized by a positive result in
the ImmunoCAP assay (Phadia Diagnostics AB, Uppsala,
Sweden) for at least one of four tested allergens (from B.
tropicalis, D. peteronyssinus, Blattella germanica and
Periplaneta americana). The children, aged 4 to 11
years, were enrolled in the SCAALA (Social Change inAsthma and Allergy in Latin America) program, a study
performed in 2005 to study risk factors for asthma and
allergies in children [14]. The 28 remaining sera were
from adult patients with moderate to severe asthma at-
tending the outpatient facility of the Centro de Estudos
em Alergias Respiratórias (CEAR), Salvador, Brazil. The
cross-reactivity between B. tropicalis recombinant aller-
gens and A. lumbricoides antigens was assessed in 20
adult sera from the CEAR patients. Informed consent
was obtained from the SCAALA project children´s par-
ents or guardians and ethical approval was granted by
the Instituto de Saúde Coletiva of the Universidade Fed-
eral da Bahia, Salvador, Brazil, and by the National Com-
mission on Ethics in Research (CONEP), Brazil. Written
consent was obtained from all adult asthma patients and
ethical approval was provided by the Ethical Committee of
the Maternidade Climério de Oliveira, Universidade Fed-
eral da Bahia, Salvador, Brazil (protocol no. 044/2010).
ELISA for human IgE antibody reactivity with B. tropicalis
recombinant proteins
ELISA was performed in microassay plate (Costar,
Bethesda, MD, USA) wells, which were incubated with
100 μg of B. tropicalis extract or 5 μg of each fusion pro-
teins (His-rBlo t 5 or His-rBlo t 21) when tested individu-
ally or 2.5 μg of each when used mixed together in the
same solid phase (rBlo t 5 plus rBlo t 21), per mL of
sodium carbonate-bicarbonate buffer, pH 9.6, overnight at
4°C. The reaction was developed as described previously [9]
and the IgE cut-off for the BtE, rBlo t 5 or rBlo t 21 assays
defined according to the mean plus two standard devia-
tions of the results obtained using sera from 10 individuals
without history of allergy and with negative SPT reaction
to the tested allergens [9].
Detection of anti-B. tropicalis IgE antibodies cross-reactive
with A. lumbricoides antigens
Inhibition ELISA was performed to investigate the pres-
ence of anti-B. tropicalis extract, anti-rBlo t 5, and anti-
rBlo t 21 IgE antibodies that cross-reacted with Ascaris
lumbricoides antigens. The inhibition was accomplished
by pre-incubating the sera with 0.3 or 3 μg/mL of A.
lumbricoides extract. These concentrations were chosen
based on previous work [9] and are within the concen-
tration range that led to the greatest differences between
non-absorbed and absorbed sera. As control for the spe-
cificity of the inhibition of the binding of anti-B.
tropicalis IgE antibodies, total IgE was determined in the
same sera, before and after absorption with Ascaris ex-
tract. The assay was carried out as described elsewhere
[9]. Results were expressed in percentage of reduction and
specific sIgE levels in sera non-adsorved and adsorved
with Ascaris extract (OD 450 nm). The percentage of re-
duction in anti-BtE anti-rBlo t 5 and anti-rBlo t 21 IgE
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duplicates of serum that had been pre-incubated with A.
lumbricoides antigen/mean OD obtained in duplicates of
untreated serum )] x 100.
Statistical analysis
The D’Agostino and Pearson test was used for verifica-
tion of the data normality. The significance of the differ-
ences among the different allergens was assessed by the
Wilcoxon signed rank test (when the data distribution
was found to be non-Gaussian). Differences with a
P value equal to or less than 0.05 were considered statis-
tically significant.
Results
Expression and validation of recombinant fusion proteins
B. tropicalis recombinant allergens were expressed and








Solid phase rBlo t 5 rBlo t 21
Figure 1 Expression and purification of recombinant proteins rBlo t 5
(B) were induced by IPTG and affinity-purified using the resin Ni-NTA agaro
were analyzed by 15% SDS-PAGE stained with Coomassie Blue. Arrows ind
t 21 with negative control sera (Ns) and positive sera – asthmatic patient (Pterminal His-tags (6 His). Once the fusion proteins were
purified, their tags (6 His) were not removed. The
achieved yields of rBlo t 5 and rBlo t 21 were 3.1 to 4.6 mg
and 2.9 to 4.5 mg per liter of bacterial culture, respectively.
Each His-tagged (rBlo t 5 and rBlo t 21) proteins produced
an expected band in SDS-PAGE (Figure 1A and B). Valid-
ation of recombinant fusion proteins was performed by
IgE immunoblotting, in which antibodies from atopic and
asthmatic individuals, but not negative control sera, were
found to react with rBlo t 5, rBlo t 21.
Antigenicity of B. tropicalis recombinant proteins
Indirect ELISA was used to evaluate the reactivity of IgE
antibodies with the fusion His-rBlo t 5 and His-rBlo t 21 fu-
sion proteins. The IgE reactivity profile of the tested sera
with the recombinant proteins is summarized in Table 1.
The panel of 35 sera from children with IgE antibodies
against BtE had IgE antibody reactivity percentages of 82.9%and rBlo t 21. The his-tagged proteins rBlo t 5 (A) and rBlo t 21
se. The samples collected during expression induction and purification
icate purified proteins. (C) Immunoblotting of the rBlo t 5 (A) and rBlo
s). MW, molecular weight.
Table 1 Reactivity of anti-B. tropicalis IgE antibodies, assessed by ELISA, using recombinant proteins
(rBlo t 5 and rBlo t 21) and crude extract as antigens, in sera containing anti-B. tropicalis extract IgE antibodies
Antigens No. of sera with positive results (%) No. of sera with negative results (%)
Sera from 35 children with anti-B. tropicalis extract IgE antibodies
rBlo t 5 29 (82.9) 6 (17.1)
rBlo t 21 28 (80.0) 7 (20.0)
Sera from 28 adult asthma patients with anti-B. tropicalis extract IgE antibodies
rBlo t 5 26 (92.8) 2 (7.2)
rBlo t 21 25 (89.3) 3 (10.7)
rBlo t 5 + rBlo t21 27 (96.4) 1 (3.6)
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rBlo t 21. The IgE reactivity percentages for the 28 sera
from adult asthma patients with IgE antibodies against BtE
were 92.8% (26 out of 28) for rBlo t 5 and 89.3% (25 out of
28) for rBlo t 21. When the indirect ELISA assay was
performed using a mixture of rBlo t 5 and rBlo t 21 aller-
gens, a positive reaction was observed in 96.4% (27 out of
28) of the sera (Table 1). Despite the fact that some sera
reacted with BtE but not with the recombinant allergens,
the levels (expressed by OD450 nm) of IgE antibodies against
rBlo t 5 in the children group, and of IgE antibodies in the
adult asthmatic patient group as detected in assays using
rBlo t 5 or a mixture of rBlot 5 plus rBlo t 21, were sig-
nificantly higher than in the assay using BtE (p < 0.0067;
p < 0.0314 and p < 0.0034, Wilcoxon signed rank test;
Figure 2, A and B). Although the percentages of IgE anti-
body reactivity to the recombinant antigens were higher in
the adult patients' serum group than in the children's
serum group, there were no statistically significant differ-
ences between these two populations (p > 0.05, Mann-
Whitney's test, data not shown). Of the total sera panel,
66.7% (42 out of 63 children's and adults' sera) reacted with
both rBlo t 5 and rBlo t 21; 92.1% of these sera (58 out of
63) reacted with at least one of the recombinant allergens
and 7.9% (5 out of 63) recognized only the B. tropicalis
crude extract (data not shown).
Cross-reactivity of IgE antibodies against B. tropicalis
extract and recombinant allergens with A. lumbricoides
antigens
There was a higher reduction in the levels of anti-B.
tropicalis crude extract IgE antibodies (median inhibition
of 39.2%) than in the levels of anti-rBlo t 5 (median inhib-
ition of 3.6%) and anti-rBlo t 21 (median inhibition of
0.1%) IgE antibodies, when they were incubated with A.
lumbricoides extract at both concentrations (Figure 3A).
However, the difference between the recombinant protein
and the BtE assays was statistically significant only with
the concentration of 3 μg/mL of A. lumbricoides extract
(p < 0.0052 for rBlo t 5 and p < 0.0020 for rBlo t 21;
Wilcoxon signed rank test). As expected, the anti-B.tropicalis crude extract IgE antibody levels were lower in
sera pre-adsorbed with A. lumbricoides extract than in the
non-adsorbed sera (Figure 3B). This difference between
the non-adsorbed and adsorbed sera was statistically sig-
nificant for both concentrations, 0.3 μg/mL and 3 μg/mL
of A. lumbricoides extract (p < 0.0217 and p < 0.0012;
Wilcoxon signed rank test). Furthermore, there was also
statistically significant difference between sera adsorved
with 0.3 μg/mL and 3 μg/mL of A. lumbricoides extract
(p < 0.0011; Wilcoxon signed rank test). The proportion
of total IgE that was reduced by incubation with A.
lumbricoides natural extract (median inhibition of 0.1%)
was lower than the proportion of anti-B. tropicalis ex-
tract IgE antibodies that was reduced by the same treat-
ment (p < 0.0008, Wilcoxon signed rank test; Figure 3).
Discussion
The B. tropicalis mite has been the target of several
studies highlighting its role as being one of the major
asthma sensitizing agent in tropical areas of the world
[15-17]. These studies have demonstrated that serum
IgE antibodies in 42% to 98% of B. tropicalis-sensitized
individuals react with Blo t 5 and Blo t 21 [2,14]. In the
present work it is shown that a large proportion of
serum IgE antibodies from BtE-sensitized children and
adults with asthma reacted with rBlo t 5 and rBlo t 21
obtained as described herein. The rBlo t 5 in acidic pH
solutions, like under purification denaturing conditions,
tends to form molecular aggregates [8]. Likely, the rBlo t
21 behave like the rBlo t 5, forming aggregates under the
same conditions, since both allergens share structural
similarities [5]. This could explain the nonspecific band
recognition by antibodies from asthmatic patient sera that
were used in immunoblotting assay of this work.
B. tropicalis is found more frequently (71.8%) than
D. pteronyssinus (39.9%) in bed dust in Salvador, a major
city in Northeast of Brazil [18]. In environments where
B. tropicalis predominates in the mite fauna, it is common
to find a high rate of co-sensitization to Blo t 5 and Blo t
21, as highlighted in our study (in 66.7% of 63 sera from
B. tropicalis sensitized individuals) [4,19]. Although several
Figure 2 Antigenicity of rBlo t 5 and rBlo t 21. IgE antibody
levels were assessed by means of indirect ELISA in sera of atopic
children (A) and asthmatic adult individuals (B) with antibodies
against whole B. tropicalis extract. Each symbol represents the result
obtained with an individual serum. Short horizontal solid lines
represent the median value of the group results. The cut-offs are
represented by horizontal dotted (0.269 for BtE assay), dashed
(0.250 for rBlo t 5 assay) or solid (0.136 for r Blo t 21) lines,
respectively. A) ** rBlo t 5 compared with Bt extract, p < 0.0067
and B)* rBlo t 5 compared with Bt extract, p < 0.0314, ** rBlo t 5
plus rBlo t 21 compared with Bt extract, p < 0.0034, Wilcoxon signed
rank test.
Carvalho et al. BMC Immunology 2013, 14:11 Page 6 of 9
http://www.biomedcentral.com/1471-2172/14/11individuals had a higher IgE antibody reactivity to rBlo t 5
and rBlo t 21 than to BtE (i.e., their sera led to higher op-
tical densities when tested in ELISA for IgE antibodies
against these recombinant allergens than against the ex-
tract; Figure 2), there is a small percentage of sera (7.9%,
corresponding to 5 out of 63 sera) that does not recognize
any of the recombinant allergens, a fact that would limit
the sensitivity of assays using these allergens. When the
two recombinant allergens were used together in the same
immunoassay, the IgE reactivity increased so that 96.4% of
the sera from asthmatic patients had anti-BtE antibodies.
Some studies indicate that mite allergy could be detected
using a mixture of two or more major recombinant aller-
gens (component-resolved diagnostics), replacing the
natural extract [20]. Furthermore, the use of multiplerecombinant allergens to detect sensitization profiles
could be very important to guide and improve immuno-
therapy for mite allergies [19-21].
This study, despite not comparing the reactivity of IgE
antibodies to rBlo t 5 and rBlo t 21 with the reactivity to
their native counterparts, suggests that recombinant al-
lergens produced as described in this paper can replace
natural allergen extracts in the diagnosis of allergies,
confirming previously published data showing that rBlo
t 5 expressed in E. coli and native rBlo t 5 have compar-
able IgE reactivity in terms of percentage of sera with
antibodies [22]. However, our data also indicate that it is
desirable to introduce other recombinant antigen(s), in
addition to rBlo t 5 and rBlo t 21, in an assay for IgE
antibodies to diagnosis hypersensitivity to B. tropicalis in
order to increase its sensitivity. Blo t 7, which has been
shown to be as reactive as Blot t 5 with IgE antibodies in
the sera from allergic children in a study also carried out
in a tropical environment [19], may be a good candidate
to be included to a pool of recombinant antigens to in-
crease the sensitivity of an immunoassay. Meanwhile,
Blo t 10 and Blo t 11, which shown to cross-react with
A. lumbricoides [23], would not be good candidates to
be included in an immunoassay with multiple recombin-
ant antigens.
The relationship between house dust mite sensitization
and triggering of asthma and other atopic diseases is
well documented [24,25]. Given the difficulty of com-
pletely eliminating the sensitizing agents of the affected
individuals' homes, immunotherapy has been playing a
key role in alleviating the clinical aspects of allergic dis-
eases. Thus, a more specific mite allergy diagnosis is ne-
cessary and it is also a key point to develop appropriate,
more specific and individualized therapies [26]. The anti-
genic extracts used in the diagnosis and immunotherapy
of allergic diseases are obtained from natural sources.
This fact brings many disadvantages, such as the pres-
ence of large amounts of non-antigenic proteins; con-
tamination by other potentially immunostimulating
compounds, like endotoxin; allergen variability in the
sample composition (depending on the season of the
year, the mite life cycle and differences in protein extrac-
tion protocols). In addition, the more sensitizing aller-
genic proteins in the mite extract can be found in low
concentrations, requiring the use of higher doses of total
extract, which is not always convenient in clinical prac-
tice [20,25,27,28].
In addition to the problems described above with the
use of whole allergenic extracts in the immunodiagnosis
of allergic diseases, there is another factor that should be
considered by the companies that commercialize these
products: the common association of B. tropicalis
sensitization with helminth infection in tropical and un-
developed regions of the world. It is in fact believed that
Figure 3 Reaction of anti-B. tropicalis, recombinant allergen IgE antibodies and total IgE to A. lumbricoides extract. Twenty adults' sera
with anti-B. tropicalis extract IgE antibodies were pre-incubated with the indicated concentrations of A. lumbricoides crude extract and tested in
indirect ELISAs using B. tropicalis crude extract (BtE) or recombinant allergens (rBlo t 5 and rBlo t 21) as antigens or assayed for total IgE levels.
The reductions in anti-Bt, anti-rBlo t 5, and anti-rBlo t 21 IgE antibody levels or total IgE levels were calculated as described in the Methods
section (A), * p < 0.0231, ** p < 0.0020 and *** p < 0.0008; Wilcoxon signed rank test. (B) Specific sIgE levels in sera non-adsorved and adsorved
with Ascaris lumbricoides extract (OD 450 nm), * p < 0.0217 ** p < 0.0012, # p < 0.0030, ## p< 0.0041; Wilcoxon signed rank test.
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lumbricoides [10,29]. Salvador city, where the donors of
the sera used in the present work live, is one helminth
parasite endemic areas in Brazil, having high prevalence
of A. lumbricoides, Trichuris trichiura and Toxocara spp
(Toxocara canis and Toxocara cati) infections. In fact,
most of the sera studied in the present work had anti-
Ascaris IgG antibodies, indicating present and/or past A.
lumbricoides infection. In this area, an overlap of para-
sitic endemicity and high prevalence of allergic diseasesis observed [30-32]. There is often dissociation between
positive skin prick test results and detectable serum IgE
antibodies in allergic individuals who are also co-
infected with A. lumbricoides [9]. This finding could be
explained by the existence of IgE antibodies, raised in re-
sponse to the helminth infection, that cross-react with
allergens but are unable to lead to degranulation of mast
cells, consequently increasing anti-allergen IgE antibody
levels but not SPT positivity [9,33]. The increase of
knowledge on cross-reactive IgE antibodies to common
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gens will certainly improve allergy diagnosis and perhaps
even immunotherapy. In the present study, pre-
incubation of sera with A. lumbricoides extract led to
varying degrees of inhibition of the binding of IgE to
mite allergens. It would also be useful to further demon-
strate this cross-reaction by inhibiting the binding of IgE
antibodies to A. lumbricoides extract by incubation of
the sera with B. tropicalis antigens. As the high levels of
IgG antibodies raised in the immune response to this
helminth hinders the detection of IgE anti-Ascaris anti-
bodies, a possible way to carry out the experiment would
be to use an assay to detect IgE antibodies more sensi-
tive than the one used in the present work.
The inhibition by adsorption with A. lumbricoides ex-
tract was higher for the binding of antibodies to B.
tropicalis crude extract than to rBlot 5 and rBlo t 21, al-
though in a few sera there was also a high level of IgE
cross-reaction between the helminth extract and the re-
combinant allergens. Cross-reactivity to both recombin-
ant allergens was observed in the same sera (data not
shown). This finding could be explained if the anti-As-
caris antibody response in these sera donors had been
more polyclonal than the immune response of the other
serum donors, so that antibodies against additional
cross-reactive epitopes would be produced. Indeed, it is
known that the repertoire of the antigens that are recog-
nized in complex antigenic mixtures may vary greatly in
different individuals of the same species [34].
The observed difference in the degree of absorption by
A. lumbricoides extract of anti-rBlo t 5 and anti-rBlo t
21 in relation to anti-BtE antibodies cannot be explained
by the presence of lower levels of anti-recombinant aller-
gen antibodies, since the amounts of anti-rBlo t 5 IgE
antibody activity, on the contrary, were found to be
higher than those of anti-BtE IgE antibody activity. Due
to this less intense cross-reactivity, assays using a mix-
ture of rBlot 5 and rBlo t 21 as antigen should be more
specific than assays using the crude extract.
IgE antibodies raised by helminths can cross-react
with several epitopes of mite antigenic extracts often
used in diagnosis of allergic diseases possibly affecting
the correct diagnosis. It becomes increasingly relevant,
therefore, to obtain more specific allergens to make an
accurate diagnosis of allergy and, consequently, im-
proving immunotherapy for mite allergy. However, the
price of assays using bacteria-produced recombinant
antigens, as compared to those of assays using crude
extracts obtained from mite cultures, is a factor that
should be taken into consideration.
Conclusions
We demonstrated that rBlo t 5 and rBlo t 21 were anti-
genic for the B. tropicalis-sensitized population evaluatedin this work. In addition, we showed that the IgE reactive
to these allergens had less cross-reactivity with A.
lumbricoides extract than anti-B. tropicalis extract IgE, as
assessed by an IgE-binding inhibition assay. Thus, rBlo t 5
and rBlo t 21 expressed in E. coli may be potential candi-
dates to be used in a pool of different recombinant aller-
gens for improving serodiagnosis assays of allergy to B.
tropicalis. More studies are needed to obtain other recom-
binant allergens in order to develop a highly sensitive and
specific assay for the diagnosis of allergy induced by B.
tropicalis allergens.
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